Huaier Granule for proteinuria in breast cancer patients
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if Huaier Granule, a traditional Chinese medicine, can reduce protein in the urine of breast cancer patients. It is for women who have proteinuria after immunotherapy or anti-angiogenic therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You have been diagnosed with breast cancer (confirmed by biopsy).
- You are currently or have previously received immunotherapy or anti-angiogenic therapy.
- You have protein in your urine for the first time, shown as +, ++, or +++ on a dipstick test.
- Your 24-hour urine protein is between 0.15 grams and 3.5 grams.
- You are in good general health (ECOG score 0 or 1) and have a life expectancy of at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Huaier Granules, a traditional Chinese medicine, can reduce protein in the urine caused by the cancer drugs Bevacizumab or Anlotinib in lung cancer patients. It may help manage a side effect that affects kidney health.
This trial tests whether Huaier granules can reduce blood “tumor marker” levels in people with breast cancer after surgery. If your marker levels are high but scans show no spread, the study may help see if the granules can keep markers from staying elevated.
This trial studies whether Huaier granules can slow or control advanced breast cancer that has not spread to internal organs (like the liver or lungs). It may help people who have limited treatment options, especially when standard stronger local treatments (surgery or radiation) aren’t being used.
This trial looks at whether adding Huaier granules to usual after-surgery treatment can improve outcomes for people with high-risk early-stage triple-negative breast cancer. It focuses on whether the added supplement is safe and helpful after standard care.
This trial tests whether a Chinese herbal medicine called Huaier granules works better than standard chemotherapy for people with pancreatic cancer that was removed by surgery. Participants can choose to take Huaier granules or standard chemotherapy, and researchers will compare outcomes.
This study tests whether Huaier granules can help prevent lung cancer from coming back after surgery. It is for people with stage II–IIIA non-small cell lung cancer who have recently had their tumor completely removed and have not had other treatments like chemotherapy or radiation.
Hear when a new Proteinuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.